Ukraine war: Russian attacks force evacuations of children
Mandatory evacuations from the frontlines are swelling the ranks of Ukraine's displaced millions.
2023-11-01 14:17
China Loosens Carbon Rules After Prices Hit Record to Ensure Power Winter Demand Is Met
China has loosened the rules governing its carbon market after prices rose to a record, to make it
2023-11-01 11:29
China’s Manufacturing Activity Contracts, Private Survey Shows
China’s manufacturing activity contracted in October, according to a private survey, signaling that the economic recovery is losing
2023-11-01 10:51
China’s Central Bank Drains Liquidity After Overnight Rate Surge
China’s central bank withdrew cash from the financial system, suggesting it sees Tuesday’s abrupt surge in short-term borrowing
2023-11-01 10:22
Daiwa Announces Share Buyback as Profit Climbs on Retail Business
Daiwa Securities Group Inc. shares rose the most in more than three years after Japan’s second-largest brokerage posted
2023-11-01 09:49
Japan Ramps Up Yen Intervention Warning After BOJ-Fueled Selloff
Traders are piling into fresh bets against the yen, triggering pushback from Japanese authorities who are threatening once
2023-11-01 09:18
Strikes on south Gaza: BBC verifies attacks in areas of ‘safety’
The BBC has analysed four strikes in south Gaza, where civilians were told to evacuate to.
2023-11-01 08:54
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
2023-11-01 07:58
Australia’s Top Three Inflation Drivers Beyond RBA’s Control
Australian inflation is being driven by climate change, geopolitical shocks and government policies — factors typically beyond the
2023-11-01 07:49
IMF Urges Australia to Tighten Policy Further to Quell Inflation
Australia needs to tighten monetary policy further as part of stepped up efforts to rein in inflation that
2023-11-01 07:46
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:30
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:17